Applications of Ultrasound and Physical Parameters in Assessing Fall Risk in Patients With Knee Osteoarthritis

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60+
SponsorNational Taiwan University Clinical Trial Center

About this trial

Falls are a significant issue for patients with knee osteoarthritis, as they can lead to hospitalization or even more severe consequences. Therefore, it is crucial to assess fall risk early in rehabilitation clinics. Sarcopenia, which is the reduction of muscle mass, increases the risk of falls. This study involved 250 adults with knee osteoarthritis, using a technology called POCUS to assess muscle mass, combined with other tests to track fall incidents over three months. The study is expected to find correlations between falls and factors like muscle mass and grip strength. This information can help doctors better predict which patients are at risk of falling and take preventive measures early. Future research will explore the effectiveness of different prevention strategies.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Males and females aged 60 and above, who are willing to sign an informed consent form.

Participants must have a clinically confirmed diagnosis of knee osteoarthritis.

Participants must have received at least one treatment in the outpatient rehabilitation department during the study period.

Participants must be able to walk independently, even with the aid of assistive devices.

Disqualifiers

Individuals who have undergone lower limb surgery or have significant lower limb deformities.

Individuals with severe cognitive impairment who are unable to understand or comply with the study procedures.

Individuals who cannot communicate in a language understandable by the research team.

Individuals with severe comorbidities that affect assessment or treatment (e.g., unable to safely complete assessments or treatments).

Trial population

Participants eligible for the study include males and females aged 60 and above who are willing to sign an informed consent form, have a clinically confirmed diagnosis of knee osteoarthritis, have received at least one treatment in the outpatient rehabilitation department during the study period, and can walk independently, even with the use of assistive devices.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

250 Participants
are grouped into 1 trial group
Group A: knee osteoarthritis

Trial outcomes

Primary outcomes

1

Fall Incident Tracking

Participants will be monitored for fall incidents over a three-month period, and the accuracy of the model predictions will be analyzed.

Time frame
Three-month period

Secondary outcomes

1

Grip strength testing

Measures the maximum strength of hand and forearm muscles using a hand dynamometer. It reflects overall muscle function and the ability to perform daily tasks. Results are reported in kilograms or pounds.

Time frame
Baseline grip strength
2

POCUS Assessment

Point-of-care ultrasound is used to measure participants' muscle mass

Time frame
Baseline POCUS Assessment
3

Sarcopenia Risk Assessment Questionnaire (SARC-F)

An assessment tool designed to determine the risk of sarcopenia in individuals. Scale: The SARC-F consists of five questions scored from 0 to 10, with higher scores indicating a greater risk of sarcopenia.

Time frame
Baseline Sarcopenia Risk Assessment Questionnaire (SARC-F)
4

Bioelectrical Impedance Analysis (BIA) Measurement

Conduct bioelectrical impedance measurements to assess body composition, including fat mass and lean body mass. Unit of Measure: Results are typically presented in kilograms and percentage for fat mass and lean body mass.

Time frame
Baseline BIA measurement

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

National Taiwan University Clinical Trial Center

Lead sponsor

National Taiwan University Hospital

Sponsor institution

This trial is not recruiting at the moment. You can still explore other options: